The Optimisticc team is supported through the Cancer Grand Challenges initiative. Learn more here

IL-22 Pathway Identified as a New Target in Colon Cancers with Mutant KRAS

August 20, 2020

IL-22 Pathway Identified as a New Target in Colon Cancers with Mutant KRAS

August 20, 2020
;

Work from Dr. Fiona Powrie’s group at University of Oxford has identified an interaction between the receptor for the immune molecule interleukin-22 (IL-22) and alterations of the KRAS gene, showing that they cooperate in promoting excessive proliferation of colon cancer cells. As KRAS mutations are present in almost half of all colorectal tumors and are poorly responsive to standard therapies, these results suggest that patients with a mutant KRAS and high IL-22 receptor levels may benefit from alternative strategies involving IL-22 modulation. This study is published in Clinical Cancer Research and is described in more detail in a University of Oxford press release.

Related Posts

Microbes are important in human health

Microbes are important in human health

Dr. Emma Allen-Vercoe: The Importance of Microbes to Human HealthIn a recent podcast by the Centre for Inquiry Canada, Emma Allen-Vercoe talks about the importance of microbiome research and how she became involved in the OPTIMISTICC project.

Future Leaders Conference

Future Leaders Conference

OPTIMISTICC Trainees Attend CGC Future Leaders Conference in Barcelona From Nov. 2-4, 2022, 14 OPTIMISTICC trainees joined members of other Cancer Grand Challenges Teams in Barcelona, Spain for the 2022 Future Leaders Conference. Drs. Caroline Young and Yasutoshi...

Importance of Patient Engagement in Research

Importance of Patient Engagement in Research

In a recent editorial Laura Porter discusses the importance of patient engagement in research in a publication titled The Importance of Patient Engagement to Improve Healthcare Research and Safety. She not only acknowledges the benefits but also the challenges of...

Optimisticc
Loading...